Press release
Global Nerve Stimulator Devices Market Expected to Grow at a CAGR of 12.6% by 2027 | Nevro Corporation, Synapse biomedical, Bio Control Medical, Cyberonics Incorporation, Boston Scientific Corporation, Abbott, Medtronic, Neuro Sigma, St. Jude Medical
According to a recently published report by Research Nester on “Global Nerve Stimulator Device Market Outlook: Industry Insights & Opportunity Assessment 2019–2027” delivers detailed overview of the global nerve stimulator device market in terms of market segmentation by product, by application, by end user and by region.Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Neurostimulation devices or nerve stimulator devices aid to provide control using the electrical stimulation of specific nerves in the body. These devices are highly beneficial in reducing pain related to neurological disorders such as chronic pain, epilepsy, major depression, Parkinson’s disease, and others. They also help to reduce the pain of paralyzed patients. These devices are operationally set in the patient’s body and functions are performed by thin wires or leads. New technologies are being developed and researchers are revealing more potential uses of this treatment which is fueling the demand for safe and cost effective treatment options. The need to develop enhanced models of neuro-simulation devices is estimated to boost the growth of the global nerve stimulator device market with a CAGR of 12.6% over the period 2019-2027.
The global nerve stimulator device market is segmented by product, application and end user. By end user, the hospitals segment is estimated to dominate the market during the forecast period. The product segment is divided into deep brain simulation devices, spinal cord simulation devices, gastric electric simulation devices, vagus nerve simulation devices, sacral nerve simulation devices and others. The application segment has been divided into Parkinson’s disease, epilepsy, pain management, essential tremor, urinary and fecal incontinence, Alzheimer’s, ischemia and others. Further the end user segment, is divided into hospitals, scientific research laboratories and others.
Request Free Sample on Nerve Stimulator Devices Market @ https://www.researchnester.com/sample-request-1656
Increasing Prevalence of Chronic Diseases to Boost the Demand for Nerve Stimulator Devices in Future
The global nerve stimulator device market is thriving on the back of increase in prevalence of chronic diseases such as migraine, epilepsy and others due to unhealthy diet and changing lifestyle of the people.
Rising geriatric population- With the rise in the geriatric population across the globe, the threat of being prone to various disease has inclined which includes different diseases such as Parkinson’s, Alzheimer’s and others that requires neurological treatment which can be done with the help of nerve stimulator devices.
North America and Europe are expected to hold major share in the market owing to the growing awareness regarding preventive care, increasing neurological diseases such as epilepsy, migraine, Parkinson’s disease, and incontinence, emerging technologies in the neurostimulation devices market and the gradual shift of preferences of the patients towards utilization of advanced medical devices. Asia Pacific is expected to grow at a high pace on the back of high economic growth, presence of a vast patient pool, improving facilities in healthcare largely owing to the expansion of both public and private sector companies that have been collaborating with multinational healthcare establishments to provide better treatment options. Latin America and the Middle East and Africa are expected to grow significantly owing to the rapidly growing healthcare infrastructure and opportunities and funds provided by the government to the manufacturers to conduct research activities for improved patient care.
The nerve stimulator devices perform specific functions which means that they are supposed to be specifically designed and programmed which make them costlier. The cost of nerve stimulator devices is high which pushes the customers towards other available options of treatment for neurological disorders which is expected to inhibit the growth of the global nerve stimulator device market.
This report also provides the existing competitive scenario of some of the key players of the global nerve stimulator market which includes company profiling of Nevro Corporation, Synapse biomedical, Bio Control Medical, Cyberonics Incorporation, Boston Scientific Corporation, Abbott, Medtronic, Neuro Sigma, St. Jude Medical and NeuroPace Incorporation.
The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global nerve stimulator device market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
For More Details: https://www.researchnester.com/reports/global-nerve-stimulator-market/1656
Contact Us
AJ Daniel
Email: sales@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nerve Stimulator Devices Market Expected to Grow at a CAGR of 12.6% by 2027 | Nevro Corporation, Synapse biomedical, Bio Control Medical, Cyberonics Incorporation, Boston Scientific Corporation, Abbott, Medtronic, Neuro Sigma, St. Jude Medical here
News-ID: 1817298 • Views: …
More Releases from Research Nester Pvt Ltd
E-commerce Market size to hit $215.2 Trillion by 2035 | Top companies include Am …
Market Outlook and Forecast
The global e-commerce market size is expected to reach USD 37.2 trillion in 2025, reflecting strong digital adoption across small enterprises, large corporations, and direct-to-consumer platforms. Driven by ecosystem modernization, fintech integration, and internet penetration, the market is forecast to expand significantly, reaching USD 215.2 trillion by 2035. During 2026-2035, the sector is projected to witness a CAGR of 19.2%, fueled by rising online shopping volumes, logistics…
PTFE Membrane Market size to exceed $5.06 Billion by 2036 | W. L. Gore & Associa …
Market Outlook and Forecast
The PTFE membrane market continues to strengthen its position as a critical materials segment within filtration, environmental protection, medical applications, and advanced manufacturing. In 2025, the market reached a valuation of USD 2.73 billion, reflecting steady adoption across end-use industries that require high-performance membranes with superior chemical resistance, thermal stability, and hydrophobicity. By 2036, the PTFE membrane market is projected to grow to USD 5.06 billion, supported…
Observability Tools and Platforms Market size to hit $172.1 Billion by 2035 | To …
Market Outlook and Forecast
The Observability Tools and Platforms Market is undergoing a transformative evolution as enterprises intensify their focus on digital resiliency, data-driven operations, and real-time performance insights. The market reached a valuation of USD 28.5 billion in 2025, supported by accelerating cloud adoption, container orchestration, AI-driven IT operations, and distributed application architectures. By 2035, the market is projected to expand substantially to USD 172.1 billion, supported by a strong…
Bioidentical Hormones Market size to surpass $4.7 Billion by 2035 | Top players …
Market Outlook and Forecast
The global Bioidentical Hormones Market is expanding steadily as clinical adoption widens and patient preference for natural hormone therapies strengthens. As of 2025, the market value stands at USD 2.8 billion, supported by rising prescription volumes for estrogen, progesterone, testosterone, and compounded bioidentical therapy formulations. By 2035, the Bioidentical Hormones Market is expected to reach USD 4.7 billion, driven by rising consumer awareness, clinical validation, and evolving…
More Releases for Parkinson’s
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082
The report provides a comprehensive analysis of company profiles listed below:
- Teva
- Roche
- Prothena
- Acorda…
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect…
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds…
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that…
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports.
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,…
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent.
Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial…
